Gene interactions in gonadal development

Annual Review of Physiology

Volumn 61, Issue , 1999, Pages 417-433

  Parker, Keith L ^a   Schedl, Andreas ^b   Schimmer, Bernard P ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

DAX 1; Sex determination; SF 1; WT1

Indexed keywords

GENE PRODUCT; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR;

CHRONOLOGY; EMBRYO DEVELOPMENT; GENE FUNCTION; GENETIC ASSOCIATION; GONAD DEVELOPMENT; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SEX DIFFERENCE; SEX DIFFERENTIATION; SEX TRANSFORMATION; TUMOR SUPPRESSOR GENE; Y CHROMOSOME;

ANIMALS; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GENES; GONADS; HUMANS; MALE; SEX DETERMINATION (GENETICS); SEX DIFFERENTIATION;

EID: 0033037106     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.61.1.417     Document Type: Review

References (95)

1. 1. Jost A. 1953. Studies on sex differentiation in mammals. Recent Prog. Horm. Res. 8:379-418
2. 2. Jost A, Vigier B, Prepin J, Perchellet J. 1973. Studies on sex differentiation in mammals. Recent Prog. Horm. Res. 29:1-41
3. 3. Hodgkin J. 1992. Genetic sex determination mechanisms and evolution. BioEssays 14:253-61
4. 4. Ford CE, Jones KW, Polani PE, Almeida JC, Briggs JH. 1959. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome). Lancet 1:711-13
5. 5. Jacobs PA, Strong JA. 1959. A case of human intersexuality having a possible XXY sex-determinating mechanism. Nature 183:302-3
6. 6. Welshons WJ, Russell LB. 1959. The Y chromosome as the bearer of male determining factors. Proc. Natl. Acad. Sci. USA 45:560-66
7. 7. Page DC, Mosher R, Simpson EM, Fisher EM, Mardon G, et al. 1987. The sex-determining region of the human Y chromosome encodes a finger protein. Cell 51:1091-104
8. 8. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, et al. 1990. A gene from the sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240-44
9. 9. Goodfellow PN, Lovell-Badge R. 1993. SRY and sex determination in mammals. Annu. Rev. Genet. 27:71-92
10. 10. Capel B. 1998 Sex in the 90s: SRY and the switch to the male pathway. Annu. Rev. Physiol. 60:497-523
11. 11. Berta P, Hawkins JR, Sinclair AH, Taylor BL, Griffiths PN, et al. 1990. Genetic evidence equating SRY and the testis-determining factor. Nature 348:448-50
12. 12. Jager RJ, Anvret M, Hall K, Scherer G. 1990. A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature 348:452-54
13. 13. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. 1991. Male development of chromosomally female mice transgenic for SRY. Nature 351:117-21
14. 14. Laudet V, Stehelin D, Clevers H. 1993. Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res. 21:2493-501
15. 15. Pevny LH, Lovell-Badge R. 1997. Sox genes find their feet. Curr. Opin. Genet. Devel. 7:338-44
16. 16. Cameron FJ, Sinclair AH. 1997. Mutations in SRY and SOX9: Testis-determining genes. Hum. Mutat. 9:388-95
17. 17. Werner MH, Huth JR, Gronenborn AM, Clore GM. 1995. Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81:705-14
18. 18. Pontiggia A, Rimini R, Harley VR, Goodfellow PN, Lovell-Badge R, Bianchi ME. 1994. Sex reversing mutations affecting the architecture of SRY-DNA complexes. EMBO J. 13:6115-24
19. 19. Grosschedl R, Giese K, Pagel J. 1994. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10:94-100
20. 20. McElreavey K, Vilain E, Abbas N, Herskowitz I, Fellous M. 1993. A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc. Natl. Acad. Sci. USA 90:3368-72
21. 21. Eicher EM, Washburn LL. 1986. Genetic control of primary sex determination in mice. Annu. Rev. Genet. 20:327-60
22. 22. Parker KL, Schimmer BP. 1997. Steroidogenic factor 1 : a key determinant of endocrine development and function. Endocrine Rev. 18:361-77
23. 23. Lala DS, Rice DA, Parker KL. 1992. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol. 6:1249-58
24. 24. Honda S-I, Morohashi K-I, Nomura M, Takeya H, Kitajima M, Omura T. 1993. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J. Biol. Chem. 268:7494-502
25. 25. Evans RM. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-95
26. 26. Shen W-H, Moore CCD, Ikeda Y, Parker KL, Ingraham HA. 1994. Nuclear receptor steroidogenic factor 1 regulates MIS gene expression: a link to the sex determination cascade. Cell 77:651-61
27. 27. Hatano O, Takayama K, Imai T, Waterman MR, Takakusu T, et al. 1995. Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120:2787-97
28. 28. Giuili G, Shen WH, Ingraham HA. 1997. The nuclear receptor SF-1 mediates sexually dimorphic expression of Müllerian inhibiting substance, in vivo. Development 124:1799-807
29. 29. Ikeda Y, Shen W-H, Ingraham HA, Parker KL. 1994. Developmental expression of mouse steroidogenic factor 1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 8:654-62
30. 30. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen W-H, et al. 1994. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8:2302-12
31. 31. Shinoda K, Lei H, Yoshii H, Nomura M, Nagano M, et al. 1995. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1-disrupted mice. Dev. Dyn. 204:22-29
32. 32. Ikeda Y, Luo X, Abbud R, Nilson JH, Parker KL. 1995. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol. Endocrinol. 9:478-86
33. 33. Luo X, Ikeda Y, Parker KL. 1994. A cell-specific nuclear receptor is essential for adrenal and gonadal development and for male sexual differentiation. Cell 77:481-90
34. 34. Sadovsky Y, Crawford PA, Woodson KG, Polish JA, Clements MA, et al. 1995. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. USA 92:10939-43
35. 35. Canteras NS, Simerly RB, Swanson LW. 1994. Organization of projections from the ventromedial hypothalamic nucleus of the hypothalamus: a Phaseolus vulgarisleucoagglutinin study in the rat. J. Comp. Neurol 348:41-79
36. 36. Crawford PA, Sadovsky Y, Milbrandt J. 1997. Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage. Mol. Cell Biol. 17:3997-4006
37. 37. Oba K, Yanase T, Nomura M, Morohashi K, Takayanagi R, Nawata H. 1996. Structural characterization of human Ad4BP (SF-1 ) gene. Biochem. Biophys. Res. Commun. 226:261-67
38. 38. Wong M, Ramayya MS, Chrousos GP, Daggers PH, Parker KL. 1996. Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J. Mol. Endocrinol. 17:139-47
39. 39. Ramayya MS, Zhou J, Kino T, Segars JH, Bondy CA, Chrousos GP. 1997. Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. J. Clin. Endocrinol. Metab. 82:1799-806
40. 40. Taketo M, Parker KL, Howard TA, Tsukiyama T, Wong M, et al. 1995. Homologs of Drosophila fushi tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. Genomics 25:565-67
41. 41. Hastie ND. 1993. The genetics of Wilms' tumor - a case of disrupted development. Annu. Rev. Genet. 28:523-58
42. 42. Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, et al. 1996. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat. Genet. 13:461-63
43. 43. Karnik P, Chen P, Paris M, Yeger H, Williams BRG. 1998. Loss of heterozygosity at chromosome 11p15 in Wilms' tumors: identification of two independent regions. Oncogene 17:237-40
44. 44. Miller RW, Fraumeni JF, Manning MD. 1964. Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital anomalies. N. Engl. J. Med. 270: 922-27
45. 45. Call K, Glaser T, Ito C, Buckler AJ, Pelletier J, et al. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-20
46. 46. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. 1990. Homozygous deletion in Wilms' tumours of a gene identified by chromosome jumping. Nature 343:774-78
47. 47. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, et al. 1990. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-69
48. 48. Ton CC, Hirvonen H, Miwa H, Weil MM, Monaghan P, et al. 1991. Positional cloning and characterization of a paired box-and homeobox-containing gene from the aniridia region. Cell 67:1059-74
49. 49. Schwanz F, Eisenman R, Knoll J, Gessler M, Bruns G. 1995. cDNA sequence, genomic organization, and evolutionary conservation of a novel gene from the WAGR region. Genomics 29:526-32
50. 50. Kent J, Lee M, Schedl A, Boyle S, Fantes J, et al. 1997. The reticulocalbindin gene maps to the WAGR region in man and to the Small eye Harwell deletion in mouse. Genomics 42:260-67
51. 51. Menke AL, van der Eb AJ, Jochemsen AG. 1998. The Wilms' tumor 1 gene: oncogene or tumor suppressor gene? Int. Rev. Cytol. 181:151-212
52. 52. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. 1991. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. USA 88:9618-22
53. 53. Bruening W, Pelletier J. 1996. A non-AUG translation initiation event generates novel WT1 isoforms. J. Biol. Chem. 271:8646-54
54. 54. Bickmore WA, Oghene K, Little MH, Seawright A, van Heyningen V, Hastie ND. 1992. Modulation of DNA binding specificity by alternative splicing of the Wilms' tumour wt1 gene transcript. Science 257:235-37
55. 55. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, et al. 1995. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391-401
56. 56. Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell R, et al. 1995. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc. Natl. Acad. Sci. USA 92:11960-64
57. 57. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, et al. 1996. RNA binding by the Wilms' tumor suppressor zinc finger proteins. Proc. Natl. Acad. Sci. USA 93:7562-66
58. 58. Kennedy D, Ramsdale T, Mattick J, Little M. 1996. An RNA recognition motif in Wilms' tumor protein (WT1) revealed by structural modelling. Nat. Genet. 12:329-32
59. 59. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, et al. 1990. The candidate Wilms' tumor gene is involved in genitourinary development. Nature 346:194-97
60. 60. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JBL. 1992. The expression of the Wilms' tumor gene, WT1, in the developing mammalian embryo. Mech. Dev. 40:85-97
61. 61. Sharma PM, Yang X, Bowman M, Roberts B, Sukumar S. 1992. Molecular cloning of rat Wilms' tumor complementary DNA and study of messenger RNA expression in the urogenital system and the brain. Cancer Res. 52:6407-12
62. 62. Hsueh SY, Kubo M, Chun SY, Haluska FG, Housman DE, Hsueh AJW. 1995. Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter. Mol. Endocrinol 9:1356-66
63. 63. Del Rio Tsonis K, Covarrubias L, Kent J, Hastie ND, Tsonis PA. 1996. Regulation of the Wilms' tumor gene during spermatogenesis. Dev. Dyn. 207:372-81
64. 64. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, et al. 1993. WT-1 is required for early kidney development. Cell 74:679-91
65. 65. Bruening W, Bardeesy N, Silverman BL, Cohn RA, Machin GA, et al. 1992. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat. Genet. 1:144-48
66. 66. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, et al. (1991) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-47
67. 67. Hastie ND. 1993. Dominant negative mutations in the Wilms' tumour (WT1) gene cause Denys-Drash syndrome - proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development. Hum. Mol. Genet. 1:293-95
68. 68. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, et al. 1993. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum. Mol. Genet. 2:259-64
69. 69. Moffet P, Bruening W, Nakgama H, Bardeesy N, Housman D, et al. 1995. Antagonism of WT1 activity by protein selfassociation. Proc. Natl. Acad. Sci. USA 92:11105-9
70. 70. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, et al. 1997. Donor splicesite mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17:467-70
71. 71. Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, et al. 1998. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum. Mol. Genet. 7:709-14
72. 72. Kikuchi H, Takata A, Akasaka Y, Fukuzawa R, Yoneyama H, et al. 1998. Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome? J. Med. Genet. 35:45-48
73. 73. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley K, et al. 1994. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat. Genet. 7:497-501
74. 74. Zanaria E, Muscatelli F, Bardoni B, Strom T, Guioli S, et al. 1994. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635-41
75. 75. Muscatelli F, Strom TM, Walker AP, Zanaria E, Recan D, et al. 1994. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism. Nature 372:672-76
76. 76. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G. 1996. Mouse Dax-1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 12:404-9
77. 77. Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, et al. 1996. Steroidogenic factor 1 and Dax-1 co-localize in multiple cell lineages: potential links in endocrine development. Mol. Endocrinol. 10:1261-72
78. 78. Nachtigal MW, Hirokawa Y, Enjeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA. 1998. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93:445-54
79. 79. Ito M, Yu R, Jameson JL. 1997. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17:1476-83
80. 80. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J. 1998. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-Cor to Steroidogenic factor 1. Mol. Cell. Biol. 18:2949-56
81. 81. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P. 1997. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390:311-15
82. 82. Burris TP, Guo W, Le T, McCabe ER. 1995. Identification of a putative Steroidogenic factor-1 response element in the DAX-1 promoter. Biochem. Biophys. Res. Commun. 214:576-81
83. 83. Yu RN, Ito M, Jameson JL. 1998. The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin up-stream promoter-transcription factor) via a composite nuclear receptor regulatory element. Mol. Endocrinol. 12:1010-22
84. 84. McDonald MT, Flejter W, Sheldon S, Putzi MJ, Gorski JL. 1997. XY sex reversal and gonadal dysgenesis due to 9p24 monosomy. Am. J. Med. Genet. 73:321-26
85. 85. Wilkie AOM, Campbell FM, Daubeney P, et al. 1993. Complete and partial XY sex reversal associated with terminal deletion of 10q: report of 2 cases and literature review. Am. J. Med. Gen. 46:597-600
86. 86. Washburn LL, Eicher EM. 1990. Normal testis determination in the mouse depends on genetic interaction of locus on chromosome 17 and the Y chromosome. Genetics 123:173-79
87. 87. Eicher EM, Washburn LL, Schork NJ, Lee B, Shown E, et al. 1997. Sex-determining genes on mouse autosomes identified by linkage analysis of C57BL/6J-YPOS sex reversal. Nat. Genet. 14:206-9
88. 88. Raymond CS, Shamu CE, Shen MM, Seifert KJ, Hirsch B, et al. 1998. Evidence for evolutionary conservation of sex-determining genes. Nature 391:691-95
89. 89. Shawlot W, Behringer R. 1995. Requirement for Lim 1 in head organizer functions. Nature 374:425-30
90. 90. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S. 1997. Defects in urogenital development in mice lacking EMX2. Development 124:1653-64
91. 91. Katohfukui Y, Tsuchiya R, Shiroishi T, Nakahara Y, Hashimoto N, et al. 1998. Male-to-female sex reversal in M33 mutant mice. Nature 393:688-86
92. 92. Ryner LC, Swain A. 1995. Sex in the '90s. Cell 81:483-93
93. 93. Wagner T, Wirth J, Meyer J, Zabel B, Held M, et al. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-20
94. 94. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller P, et al. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-30
95. 95. Swain A, Narvaez V, Burgoyne P, Camerino G, Lovell-Badge R. 1998. Dax 1 antagonizes Sry action in mammalian sex determination. Nature 391: 761-67